To register for the conference and schedule a one-on-one meeting with Reviva management, please use the link HERE.

CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) had its price objective lowered by HC Wainwright from $14.00 to $11.00 ...

On November 14 th, 2024, Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported third quarter 2024 financial and operational results and filed its Form 10-Q with the SEC. Reviva provided ...

Shares of NASDAQ RVPH opened at $1.91 on Friday. Reviva Pharmaceuticals has a twelve month low of $0.60 and a twelve month high of $4.83. The firm has a 50-day moving average of $1.71 and a two ...

In recent trading, Reviva Pharmaceuticals Holdings Inc (RVPH) stock price has shown some volatility, fluctuating -19.80% over the last ...

Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported preliminary results from its open label extension (OLE) portion of the Phase III RECOVER trial. Brilaroxazine showed a favorable long ...

Stock Trading Recap. On Friday, Reviva Pharmaceuticals Holdings Inc (RVPH) stock saw a decline, ending the day at $1.77 which represents ...

Vandana Singh Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) shares are ...

Short interest in Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) decreased during the last reporting period, falling from 8.80M to 5.64M. This put 13.56% of the company's publicly available ...